Research & Evidence Base Flashcards
7 cards from real CLT practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Research & Evidence Base flashcards as text
Which specific evidence-based outcome did Amador's 2007 controlled study emphasize as the primary benefit of using LEAP with patients with schizophrenia?
Answer: Improved therapeutic alliance leading to better adherence
Amador's research focused on improved therapeutic alliance as the mechanism by which LEAP reduced nonadherence, not direct symptom change.
In research measuring the LEAP effect on family members using the approach, which outcome showed statistically significant improvement?
Answer: Greater willingness by the patient to seek outpatient care
Studies involving family-delivered LEAP found the strongest effect on patients' willingness to engage with outpatient treatment, not direct insight change.
Evidence-based practice guidelines recommend LEAP most strongly for which clinical population?
Answer: Individuals with psychotic disorders and anosognosia who refuse treatment
LEAP is most strongly indicated for individuals with psychotic disorders who exhibit anosognosia and resist treatment, which is the population driving its research base.
Research on the 'Agreeing' component of LEAP shows that finding common ground with patients is clinically effective primarily because it does what?
Answer: Reduces adversarial dynamics without requiring agreement on diagnosis
The Agreeing step reduces conflict by identifying genuine shared concerns, never requiring the clinician to endorse false illness beliefs.
A meta-analysis of intervention studies targeting anosognosia in schizophrenia found which approach yielded the most consistent treatment engagement outcomes?
Answer: Combined motivational and relational techniques like LEAP
Meta-analytic evidence supports combined motivational and relational approaches as more effective for engagement than standalone psychoeducation or cognitive remediation.
In LEAP outcome research, which measurement time point shows the most durable medication adherence effects?
Answer: 6–12 months follow-up
Studies tracking LEAP outcomes find that adherence gains are most durable and clinically meaningful at 6–12 month follow-up assessments.
Research into the 'Listening' phase of LEAP found that open-ended reflection without argumentation reduced which specific patient behavior?
Answer: Defensive resistance and hostility toward treatment
Non-confrontational listening directly reduces defensive resistance and hostility, creating the relational conditions necessary for later partnership steps.